Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children.
Journal article
Herbert NG. and Goulder PJR., (2023), Curr Opin HIV AIDS, 18, 229 - 236
Hepatitis B Virus Prevalence and Mother-to-Child Transmission Risk in an HIV Early Intervention Cohort in KwaZulu-Natal, South Africa.
Journal article
Millar J. et al, (2023), Open Forum Infect Dis, 10
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile.
Journal article
Nguyen AN. et al, (2023), Pediatr Res
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.
Journal article
Johnson SA. et al, (2023), Clin Exp Immunol, 212, 249 - 261
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Journal article
Huo J. et al, (2023), Cell Rep, 42
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Journal article
Fidler S. et al, (2023), Clin Infect Dis, 76, 201 - 209
Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.
Journal article
Adriano Vieira V. et al, (2023), JCI Insight
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents.
Journal article
Jay C. et al, (2023), Front Immunol, 14
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members.
Journal article
Jay C. et al, (2023), Front Immunol, 14
Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion.
Journal article
Jay C. et al, (2023), Front Immunol, 14
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
Journal article
Dolton G. et al, (2022), Cell, 185, 2936 - 2951.e19
Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatment
Journal article
Bengu N. et al, (2022), Medicine (United States), 101
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence.
Journal article
Fernández-Luis S. et al, (2022), BMC Public Health, 22
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Journal article
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
Journal article
Khan K. et al, (2022), Clinical Infectious Diseases, 75, E857 - E864
Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and with Human Immunodeficiency Virus on Antiretroviral Therapy during the First South African Infection Wave
Journal article
Snyman J. et al, (2022), Clinical Infectious Diseases, 75, E249 - E256
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Journal article
Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Journal article
Sampson O. et al, (2022), J Immunol Methods, 504
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nat Commun, 13